Lobbyist · LDA.gov number 107185

COREY MALMGREN

34 reportsConfirmed from the official record

COREY MALMGREN is named as a lobbyist in 34 lobbying reports we hold, filed by 1 registrant for 34 clients.

Every lobbyist

Earlier government jobs, as reported

A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.

No report we hold lists a covered position for COREY MALMGREN.

Registrants and clients

Clients: ACADEMY OF MANAGED CARE PHARMACY; ACADIA PHARMACEUTICALS, INC.; ACCOUNTABLE FOR HEALTH; AGILON HEALTH, INC.; ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS; ALNYLAM PHARMACEUTICALS, INC.; AMGEN INC; ASSOCIATION FOR CLINICAL ONCOLOGY; ASTELLAS PHARMA US, INC.; ASTRAZENECA; BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.); CORROHEALTH, INC.; DAIICHI SANKYO, INC.; DH DIAGNOSTICS LLC; ELEVANCE HEALTH, INC.; EMD SERONO, INC.; GILEAD SCIENCES, INC.; HUMANA, INC.; INCYTE CORPORATION; MERCK & CO., INC; MYRIAD GENETICS, INC.; NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU); ORGANON, LLC; PATIENT SQUARE CAPITAL; PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION; PHLOW CORPORATION; PHRMA; SIEMENS HEALTHINEERS; SOLVENTUM CORPORATION; TAKEDA PHARMACEUTICALS AMERICA, INC.; THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION); TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY); TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS); UNITED THERAPEUTICS CORPORATION.

Bills named where this lobbyist is listed, and how the House and the Senate voted

39 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.

Bills named in reports that list COREY MALMGREN
BillStatusHow the House and the Senate voted
H.R. 946ORPHAN Cures ActIntroducedNo recorded vote in our record
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.IntroducedNo recorded vote in our record
H.R. 1672Maintaining Investments in New Innovation ActIntroducedNo recorded vote in our record
H.R. 3164Ensuring Community Access to Pharmacist Services ActIntroducedNo recorded vote in our record
H.R. 3288Access to Prescription Digital Therapeutics Act of 2025IntroducedNo recorded vote in our record
H.R. 3514Improving Seniors’ Timely Access to Care Act of 2025IntroducedNo recorded vote in our record
H.R. 3890Resident Physician Shortage Reduction Act of 2025IntroducedNo recorded vote in our record
H.R. 3955RAPID Reserve ActIntroducedNo recorded vote in our record
H.R. 4191MAPS ActIntroducedNo recorded vote in our record
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies ActIntroducedNo recorded vote in our record
H.R. 5269RESULTS ActIntroducedNo recorded vote in our record
H.R. 5526Biosimilar Red Tape Elimination ActIntroducedNo recorded vote in our record
H.R. 6130ASAP ActIntroducedNo recorded vote in our record
H.R. 6197Health Tech Investment ActIntroducedNo recorded vote in our record
H.R. 6509SAFE Drugs Act of 2025IntroducedNo recorded vote in our record
H.R. 7352PASTEUR Act of 2026IntroducedNo recorded vote in our record
H.R. 7871MVP ActIntroducedNo recorded vote in our record
H.R. 8129To amend title XVIII of the Social Security Act to establish a full risk ACO program.IntroducedNo recorded vote in our record
H.R. 8800National Defense Authorization Act for Fiscal Year 2027Passed the HouseNo recorded vote in our record
H.R. 8857Next GEN Act of 2026IntroducedNo recorded vote in our record
H.Res. 1331Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".IntroducedNo recorded vote in our record
S. 1041Affordable Prescriptions for Patients ActPassed the SenateNo recorded vote in our record
S. 1096Preserve Access to Affordable Generics and Biosimilars ActReported by committeeNo recorded vote in our record
S. 1399Health Tech Investment ActIntroducedNo recorded vote in our record
S. 1637MVP ActIntroducedNo recorded vote in our record
S. 1702Access to Prescription Digital Therapeutics Act of 2025IntroducedNo recorded vote in our record
S. 1784MAPS ActIntroducedNo recorded vote in our record
S. 1816Improving Seniors’ Timely Access to Care Act of 2025IntroducedNo recorded vote in our record
S. 1862ORPHAN Cures ActIntroducedNo recorded vote in our record
S. 1954Biosimilar Red Tape Elimination ActReported by committeeNo recorded vote in our record
S. 2062RAPID Reserve ActIntroducedNo recorded vote in our record
S. 2426Equitable Community Access to Pharmacist Services ActIntroducedNo recorded vote in our record
S. 2439Resident Physician Shortage Reduction Act of 2025IntroducedNo recorded vote in our record
S. 2658Medication Affordability and Patent Integrity ActReported by committeeNo recorded vote in our record
S. 2761RESULTS ActIntroducedNo recorded vote in our record
S. 3097Health Information Privacy Reform ActReported by committeeNo recorded vote in our record
S. 3267ASAP ActIntroducedNo recorded vote in our record
S. 4784National Defense Authorization Act for Fiscal Year 2027Reported by committeeNo recorded vote in our record
S. 4875PASTEUR Act of 2026IntroducedNo recorded vote in our record

Issues named: Health Issues (26), Medicare/Medicaid (26), Budget/Appropriations (4), Trade (domestic/foreign) (3), Copyright/Patent/Trademark (1), Taxation/Internal Revenue Code (1).

Every report

Lobbying reports that name COREY MALMGREN
ClientRegistrantKind, as filedPostedReport
ACADIA PHARMACEUTICALS, INC.Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
SIEMENS HEALTHINEERSHealth IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
DH DIAGNOSTICS LLCMedicare/Medicaid, Budget/Appropriations, Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
UNITED THERAPEUTICS CORPORATIONHealth IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ACADEMY OF MANAGED CARE PHARMACYHealth IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
PATIENT SQUARE CAPITALHealth IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)Medicare/Medicaid, Health Issues, Copyright/Patent/TrademarkTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU)Health Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION)Medicare/Medicaid, Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ELEVANCE HEALTH, INC.Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ASSOCIATION FOR CLINICAL ONCOLOGYHealth IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
CORROHEALTH, INC.Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
AGILON HEALTH, INC.Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ACCOUNTABLE FOR HEALTHMedicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
TAKEDA PHARMACEUTICALS AMERICA, INC.Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
PHRMAMedicare/Medicaid, Trade (domestic/foreign), Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
MERCK & CO., INCMedicare/Medicaid, Trade (domestic/foreign), Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDSHealth IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
INCYTE CORPORATIONMedicare/Medicaid, Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
EMD SERONO, INC.Health Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ASTRAZENECAHealth Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
AMGEN INCMedicare/Medicaid, Health IssuesTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ALNYLAM PHARMACEUTICALS, INC.Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
SOLVENTUM CORPORATIONHealth Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
PHLOW CORPORATIONHealth Issues, Budget/AppropriationsTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATIONHealth Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ORGANON, LLCHealth Issues, Medicare/Medicaid, Budget/AppropriationsTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
MYRIAD GENETICS, INC.Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
HUMANA, INC.Medicare/Medicaid, Taxation/Internal Revenue CodeTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
GILEAD SCIENCES, INC.Health Issues, Medicare/Medicaid, Budget/AppropriationsTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
DAIICHI SANKYO, INC.Health Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)Health Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
ASTELLAS PHARMA US, INC.Health Issues, Medicare/MedicaidTIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)Medicare/Medicaid, Health Issues, Trade (domestic/foreign)TIBER CREEK GROUP2nd Quarter - ReportThe report on LDA.gov

Campaign gifts this lobbyist reported

Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.

Contributions reported by COREY MALMGREN
MemberPaid to, as reportedAmountDateReport
Sarah McBride DDemocratMCBRIDE FOR DELAWARE, INCFrom SELF$1,000The report on LDA.gov

Where this comes from

Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .

2026-Q2: every page of LDA.gov's list saved and read.

A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.

Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.

Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote